Mir-3651 participates in the growth cycle of hepatocellular carcinoma cells and promotes the malignant metastasis via the pi3k/akt/mtor signalling pathway

HIGHLIGHTS

• who: PI and collaborators from the Department of General Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China have published the research work: miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway, in the Journal: Journal of Oncology of 19/09/2022

SUMMARY

Hepatocellular carcinoma (HCC) is one frequently seen malignant tumor worldwide, with a mean annual increase of over 800,000 patients. According to the survey, HCC in over 70% of HCC patients was . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.